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Proc. Nati Acad. Sci Contributed by Richard K. Gershon, December 31, 1981 ABSTRACT T cells that have been immunized to express optimal levels of contact hypersensitivity upon adoptive transfer to normal animals can be inhibited from doing so by incubating them with an antigen-specific T suppressor factor. This factor is composed of at least two subunits which come from cells expressing different Ly phenotypes; an antigen-specific antigen-binding "subfactor" is made by an Ly-1 cell and a non-antigen-binding one is made by an Ly-2 cell. Neither of these cells nor their products express detectable amounts ofmajor histocompatibility gene products. The mode of immunization plays an important role in determining which ofthese subfactors will be produced. Painting the skin with a reactive hapten immunizes Ly-1 cells that secrete antigen-binding material, whereas intravenous injection of trinitrobenzenesulfonic acid activates Ly-2 cells to produce a second subunit that does not see antigen. There is reason to believe that the molecule that does not bind to antigen does have some antigen specificity. An analysis ofthe data at hand suggests that the antigen specificity stems from an interaction of the two subunits described with yet another subunit and that biological activity is dependent upon three macromolecules. Thus, the complex level of cellular interactions that regulate immunity may also be reflected in a similar type of complexity in the interactions between their biologically active cell-free products.
Antigen-specific suppressor T cells play an important role in immunoregulation. It has been found in studies of in vitro antibody responses that the activity of these cells is not autonomous. They require help from a special T helper subset that can be identified by its expression ofa unique profile ofcell surface alloantigens (Ly-l+; Ly-2-; I-J+; Qa-l+) to express optimal effector activity (1) . The suppressor effector cells also express a cell surface phenotype (Ly-l-; Ly-2+; I-J+; Qa-l+) by which they can be identified (2) . Thus, some cells act as inducers of antigen-specific suppression while others act as effector cells. The biological activities of both types of cells can be replaced by substances that they release (3, 4) . These collections of biologically active molecules have been referred to as factors. The factor made by Ly-1 inducer cells consists of two macromolecules: one that sees antigen and another that expresses the I-J marker (5) . Both molecules come from Ly-1 cells and can be shown to associate with one another in their biologically active form. Biologically active products of somatic cell hybrids have also been shown to be composed of two similar chains (6, 7) . However, not all suppressor molecules have been demonstrated to consist of two subunits that can be separated and identified (8) .
A series of suppressor factors that can inhibit contact sensitivity (CS) reactions to reactive haptens has been described (8, (9) (10) (11) . Some of these appear to act on the "afferent" arm of the immune response in that they prevent immunization, and another group appears to act at the "efferent" arm. The latter group ofcells can inhibit the functions ofimmune effector cells. The cell surface phenotypes of the cells responsible for suppressing contact hypersensitivity responses have not been as well characterized as the suppressor factors that inhibit antibody responses as described above.
One hapten-specific product that inhibits the "efferent" arm of the CS response to picryl chloride (PCI, 2-chloro-1,3,5-trinitrobenzene), described by Asherson and Zembala in 1974 (12) , has been studied extensively in our laboratory (13, 14) . We have found that the optimal way to produce this factor is to inject mice intravenously with 2,4,6-trinitrobenzenesulfonic acid (TNBSA) and subsequently to paint their flank skin with PCI. The cultured spleen and lymph node cells ofmice so immunized release significant amounts of efferent suppressor factor.
We have attempted to determine why two separate forms of antigen inoculation are required to get optimal suppressor factor produced and to characterize the cells responsible for the factor's biological activity. Unlike any suppressor factor heretofore described, the biological activity of this particular factor is dependent upon an interaction of two macromolecules made by cells of different Ly phenotypes. Painting the flank skin with PC1 activates an Ly-l; Ly-2-; I-J-cell, which releases an antigen-specific product that can be isolated on hapten affinity columns. This molecule has no biological activity that we can measure; however, if it is mixed with the cell-free products of cultured spleen and lymph node cells from mice immunized with TNBSA it acquires potent suppressive activity. The cell responsible for the production of the second macromolecule appears to be antigen specific, although its product does not bind to antigen with a measurable avidity. The cell itself expresses the phenotype of suppressor effector cells (e.g., Ly-1 Ly-2+; I-l-).
MATERIALS AND METHODS
Animals. CBA/J mice (6-to 8-week-old males) were obtained from the Jackson Laboratories and maintained in the Department of Comparative Medicine, Yale University.
Abbreviations: CS, contact sensitivity, PC1, picryl chloride; TNBSA, 2,4,6-trinitrobenzenesulfonic acid; Ox, 4-ethoxymethylene-2-phenyloxazolone; TsF, T suppressor factor; BGG, bovine gamma globulin; TNP, 2,4,6-trinitrophenyl; MHC, major histocompatibility complex. f To whom reprint requests should be addressed.
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. plement. The treated cells were mixed together and added to immune cells; the cell mixtures were then transferred to adoptive recipients, which were tested for the expression of CS immediately after cell transfer. Two major points are made by the data. One is that the previously described suppressive regimen does not require that both immunization procedures be done in the same mouse, even though both types of immunization are necessary for suppression to be seen. The second is that the two forms ofimmunization activate cells with different Ly phenotypes. Comparison ofgroup 3 with group 4 shows that the relevant cell from PCl-immunized mice does not express Ly-2, and comparison with group 5 shows that it does express Ly-1 (i.e., it is an Ly-1 T cell). Similarly, comparison of group 3 with group 6 shows that the TNBSA-immune cells express Ly-2 and comparison with group 7 shows that they do not express Ly-1 (i.e., these are Ly-2 cells). Comparison of group 8 the PCI-immune cells in reconstituting biological activity (group 6).
The Two Separate Subfactors Show Antigen Specificity in their Ability to Interact with Each Other to Produce Suppressive Activity. We also asked whether either of the two subfactors described had antigen specificity. To do this we immunized some mice by painting their skin with the reactive hapten Ox in lieu of PCI, and replaced the TNBSA immunization by Ox conjugated to mouse erythrocytes. In all cases the cells that were to make the Ly-1 subfactor and the cells that were to make the Ly-2 subfactor were cultured separately and the various supernatants were harvested and mixed together. AntiLy treatments of these cells were not done.
The results in Table 3 show that: (i) the two subfactors must come from cells immunized with the same hapten (TNP or Ox) to produce their suppressive effect, and (ii) the finding of subfactors produced by PC1 and TNBSA immunization can be extrapolated to the Ox system.
Only One of the Two Subfactors (the Product of the PCIImmune Ly-1 Cell) Binds Antigen. We next asked if either or both of the subfactors bound to antigen. To do this we made TNP-'BGG-Sepharose columns and passed the individual factors through thecolumns. Elution was performed with excess hapten. Table 4 shows that the eluate from the column over which the product of the cells immunized with PC1 was passed could not produce suppressive activity when mixed with the eluate from the TNBSA-immune cellular product (group 5), but could when mixed with the effluent (group 6), whereas the PC1 effluent would not work with the TNBSA effluent (group 7). Thus, the PCl subfactor bound to antigen whereas the TNBSA subfactor did not.
DISCUSSION
The principal finding we have presented is that two molecules (subfactors) coming from cells that express distinct cell surface phenotypes are required for a particularform ofantigen-specific suppressive activity. Although the precise molecular mechanism by which these two subfactors work to produce a complete factor is totally unknown, the establishment of such a finding is important for analyses of how antigen-specific biologically active materials are made and how they produce their specific activity.
We have started analyzing the chemical nature of the two macromolecules reported above. The antigen-specific molecule made by the Ly-i cell is easy to affinity-purify on a hapten immunoabsorbent. Additionally, we have made a heteroantiserum in a rabbit that recognizes this molecule. Preliminary analysis by sodium dodecyl sulfate/polyacrylamide gel electrophoresis suggests that this molecule has a molecular weight of 68,000. The material made by the TNBSA-immunized Ly-2 cell has been harder to purify because it does not bind to antigen. However, we have made a monoclonal antibody that recognizes this product. Interestingly, this product also has an approximate molecular weight of 68,000.
The simplest postulate as to the mechanism by which these two subfactors might work together in an antigen-specific way is that they combine and act in combination as a single unit with two functions. However, our attempts to demonstrate combination, using both solid-phase and fluid-phase conditions, have failed to reveal any evidence that the two subfactors associate with one another. We have also been unable to demonstrate any genetic restrictions in the ability of the subfactors to interact with one another. However, one must interpret this type of negative evidence quite cautiously.
However, assuming that our preliminary results are correct and that the chains do not combine, the question that arises is: "How does the subunit that binds neither to antigen nor to its antigen-binding subfactor impart an antigen-specific interactive event?" The simplest answer to this question would be that the two haptens that we have studied (TNP and Ox) produce different classes ofsubfactors and that what seems to be an antigen- Immunology: Ptak et al.
Proc. Natd Acad. Sci. USA 79 (1982) specific interaction is simply due to functional differences ofthe subunits and has nothing to do with antigen per se. This interpretation is unsatisfying because there is no reason to suspect that the two "complete" factors do not act in a similar way to one another.
Thus, ifthe apparent antigen specificity is due to a real specificity, it would seem that one must postulate that the suppressive interaction is given a specificity by a third molecule that sees something on the antigen-specific subfactor and something on the nonspecific one, and that in so doing produces a complete antigen-specific factor made up ofthree separate macromolecules or subfactors. This third hypothetical macromolecule could be made by the assay cells with which the other two subfactors are mixed or by the host into which the assay cells are inoculated. Specificity could be achieved if the hypothesized third subfactor saw antigen and formed an antigen bridge with the antigen-binding molecule, and saw something akin to idiotype (or anti-idiotype) on the non-antigen-binding molecule (the reason for postulating idiotype or anti-idiotype is that this is the second mechanism known to immunologists that can give antigen specificity). In a preliminary test ofthis notion we have depleted the assay population of Ly-2 cells (note: it is the Ly-1 cell in the assay population that transfers the adoptive immunity) and have found under those circumstances the complete factor is no longer suppressive. This evidence suggests that a third macromolecule is indeed required for biological activity.
The fact that we have been unable to find any major histocompatibility (MHC) determinants on either ofthe two subunits we are studying is surprising. If one wished to make the generalization, for which no previous exceptions have been described , that all antigen-specific immunoregulatory factors express MHC determinants, one could postulate that the proposed third macromolecule, which is involved in bringing the two macromolecules we have described together, does express an MHC determinant, and in particular I-J.
Another question one might address is: "Why, when both forms ofimmunization are performed in a single mouse, can one obtain a complete factor in which both macromolecules can be isolated on an antigen-specific affinity column (14)?" One possible explanation is that the association we have found using complete factors from individual mice is artifactual, stemming from the highly reactive nature of the chemical compounds we have used to immunize the donor mice. Thus, it is quite possible that some of the material induced by the TNBSA actually has TNP determinants on it. This subfactor may associate with the subfactor produced by the PCl-immunized Ly-1 cells simply due to the presence of TNP on the TNBSA-induced subfactor.
We have been able to produce this type of artifactual binding experimentally, and we tentatively conclude that this accounts for the association found. Ofcourse one must consider the possibility that the hypothetical third subfactor is produced by mice immunized with both PC1 and TNBSA. However, if this were the case one would have to postulate the need for four subfactors because the complete TsF made by doublyimmunized mice still needs an Ly-2 helper. in the assay population to work effectively.
In sum, we have shown that the biological activity of soluble products produced by various T cell subsets depends on a complex interaction between at least two and probably three macromolecules for biological activity to be seen. Many postulates could be put forth for the functional role of each ofthe separate macromolecules. Functions that may be needed for the biological event to occur include: (i) an antigen-bridging reaction with cell surface receptors, (ii) ajoining ofmacromolecules into functional units, and (iii) delivery of the biologically active peptide to the appropriate receptor on the target cell. At the present time the data are inadequate for rational speculation as to which macromolecule is performing which function, except of course for the antigen-specific one, which we suspect is involved in forming an antigen bridge with the acceptor cell. However, because there is such a high level of complexity in the interactions between the cells responsible for immunoregulation, it is useful and important in analyzing these cellular interactions to consider that the molecular interactions may have similar levels of complexity.
